NovoLog PenFill and Ramucirumab Intravenous
Determining the interaction of NovoLog PenFill and Ramucirumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
Generic Name: ramucirumab
Brand name: Cyramza
Synonyms: Ramucirumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NovoLog PenFill-Ranexa
- NovoLog PenFill-Ranibizumab
- NovoLog PenFill-Ranibizumab Intraocular
- NovoLog PenFill-Ranibizumab ophthalmic
- NovoLog PenFill-Ranitidine
- NovoLog PenFill-Ranitidine Capsule
- Ramucirumab Intravenous-Novoseven
- Ramucirumab Intravenous-NovoSeven RT
- Ramucirumab Intravenous-NovoSeven RT with MixPro injection
- Ramucirumab Intravenous-Novothyrox
- Ramucirumab Intravenous-Noxafil
- Ramucirumab Intravenous-Noxafil (Posaconazole Delayed-Release Tablets)